1.
J Eur Acad Dermatol Venereol
; 25(1): 110-2, 2011 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20477924
2.
Clin Exp Dermatol
; 34(4): 552-4, 2009 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19522990
3.
Actas Dermosifiliogr
; 98(1): 50-3, 2007.
Artigo
em Espanhol
| MEDLINE
| ID: mdl-17374335
RESUMO
Kaposi's sarcoma is a multifocal neoplastic process with four clinical variants, all of them induced by human herpes virus 8. Currently there is no treatment of choice and it depends on the extension and location of the lesions as well as on the clinical type of the disease. Alitretinoin gel 0.1 % is approved for the treatment of cutaneous lesions of AIDS-associated Kaposi's sarcoma. The majority of its side effects appear at the site of application and can lead to therapy withdrawal. We report a case of Kaposi's sarcoma treated with topical alitretinoin that had a favourable evolution in spite of an intense local reaction.
Assuntos
Antineoplásicos/administração & dosagem , Sarcoma de Kaposi/tratamento farmacológico , Neoplasias Cutâneas/tratamento farmacológico , Tretinoína/administração & dosagem , Administração Tópica , Idoso de 80 Anos ou mais , Alitretinoína , Feminino , Humanos
4.
Actas Dermosifiliogr
; 100(5): 427-8, 2009 Jun.
Artigo
em Espanhol
| MEDLINE
| ID: mdl-19558922
5.
J Eur Acad Dermatol Venereol
; 21(7): 1005-6, 2007 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17659031